|
Name of the product: TACROLIMUS 0.5 DOSA (*)
Active ingredient: Tacrolimus 0.5 mg
Dosage form: hard capsules
Name of the product: TACROLIMUS 1 DOSA (*)
Active ingredient: Tacrolimus 1 mg
Dosage form: hard capsules
Name of the product: TACROLIMUS 5 DOSA (*)
Active ingredient: Tacrolimus 5 mg
Dosage form: hard capsules
Dispensing requirements: Rx only
Argentine Industry
Composition:
TACROLIMUS 0.5 DOSA:
Each capsule contains tacrolimus 0.5 mg, sodium croscarmellose and magnesium stearate.
TACROLIMUS 1 DOSA:
Each capsule contains tacrolimus 1 mg, sodium croscarmellose and magnesium stearate.
TACROLIMUS 5 DOSA:
Each capsule contains tacrolimus 5 mg, sodium croscarmellose and magnesium stearate.
Indications:
TACROLIMUS DOSA is indicated for the prevention and treatment of organ rejection after allogeneic liver or kidney transplants; it is recommended to administer concomitantly with adrenal corticosteoids.
Therapeutic action:
Immunosuppressant.
Storage:
Keep at temperature below 25º C in the marketed packing. Protect from the light.
Marketed presentations:
TACROLIMUS 0.5 DOSA:
Packs containing 50 and 100 capsules.
Packs containing 500 capsules, for use in hospitals.
TACROLIMUS 1 DOSA:
Packs containing 50 and 100 capsules.
Packs containing 500 capsules, for use in hospitals.
TACROLIMUS 5 DOSA:
Packs containing 50 and 100 capsules.
Packs containing 500 capsules, for use in hospitals.
Medicinal speciality authorised by the Ministry of Health.
Certificate Nº 53383
Laboratorio DOSA S.A.
Girardot 1369, (C1427AKC) Buenos Aires, Argentine
Pharmaceutical Director: María C. Terzo, Pharmacist
|
